Clovis Oncology, Inc. Liabilities, Fair Value Adjustment
Clovis Oncology, Inc. reported Liabilities, Fair Value Adjustment of $24.94 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-04.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:LiabilitiesFairValueAdjustment · last filed 2016-11-04
- Clovis Oncology, Inc. liabilities, fair value adjustment for the quarter ending 2016-09-30 was $0.00.
- Clovis Oncology, Inc. liabilities, fair value adjustment for the quarter ending 2016-06-30 was $25.45M.
- Clovis Oncology, Inc. liabilities, fair value adjustment for the quarter ending 2016-03-31 was -$516.00K.
- Clovis Oncology, Inc. liabilities, fair value adjustment for the quarter ending 2015-12-31 was $26.88M, a 1342.17% increase year-over-year.
- Clovis Oncology, Inc. liabilities, fair value adjustment for fiscal 2015 was $24.61M.
- Clovis Oncology, Inc. liabilities, fair value adjustment for fiscal 2014 was -$707.00K.
- Clovis Oncology, Inc. liabilities, fair value adjustment for fiscal 2013 was -$405.00K.
| Period end | Liabilities, Fair Value Adjustment 3 month | Liabilities, Fair Value Adjustment 6 month | Liabilities, Fair Value Adjustment 9 month | Liabilities, Fair Value Adjustment 12 month |
|---|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $25.45M derived: sum of 2 quarters · filed 2016-11-04 | $24.94M 10-Q · filed 2016-11-04 | $51.82M derived: sum of 4 quarters · filed 2016-11-04 |
| 2016-06-30 | $25.45M 10-Q · filed 2016-08-09 | $24.94M 10-Q · filed 2016-08-09 | $51.82M derived: sum of 3 quarters · filed 2016-08-09 | $51.03M derived: sum of 4 quarters · filed 2016-11-04 |
| 2016-03-31 | -$516.00K 10-Q · filed 2016-05-09 | $26.37M derived: sum of 2 quarters · filed 2016-05-09 | $25.58M derived: sum of 3 quarters · filed 2016-11-04 | $24.82M derived: sum of 4 quarters · filed 2016-11-04 |
| 2015-12-31 | $26.88M 10-K · filed 2016-02-29 | $26.10M derived: sum of 2 quarters · filed 2016-11-04 | $25.34M derived: sum of 3 quarters · filed 2016-11-04 | $24.61M 10-K · filed 2016-02-29 |
| 2015-09-30 | -$783.00K 10-Q · filed 2016-11-04 | -$1.55M derived: sum of 2 quarters · filed 2016-11-04 | -$2.27M 10-Q · filed 2016-11-04 | -$407.00K derived: sum of 4 quarters · filed 2016-11-04 |
| 2015-06-30 | -$764.00K 10-Q · filed 2016-08-09 | -$1.49M 10-Q · filed 2016-08-09 | $376.00K derived: sum of 3 quarters · filed 2016-08-09 | -$512.00K derived: sum of 4 quarters · filed 2016-08-09 |
| 2015-03-31 | -$724.00K 10-Q · filed 2016-05-09 | $1.14M derived: sum of 2 quarters · filed 2016-05-09 | $252.00K derived: sum of 3 quarters · filed 2016-05-09 | -$609.00K derived: sum of 4 quarters · filed 2016-05-09 |
| 2014-12-31 | $1.86M 10-K · filed 2016-02-29 | $976.00K derived: sum of 2 quarters · filed 2016-02-29 | $115.00K derived: sum of 3 quarters · filed 2016-02-29 | -$707.00K 10-K · filed 2016-02-29 |
| 2014-09-30 | -$888.00K 10-K · filed 2016-02-29 | -$1.75M derived: sum of 2 quarters · filed 2016-02-29 | -$2.57M derived: sum of 3 quarters · filed 2016-02-29 | |
| 2014-06-30 | -$861.00K 10-K · filed 2016-02-29 | -$1.68M derived: sum of 2 quarters · filed 2016-02-29 | ||
| 2014-03-31 | -$822.00K 10-K · filed 2016-02-29 | |||
| 2013-12-31 | -$405.00K 10-K · filed 2016-02-29 |